Treatment of attention-deficit/hyperactivity disorder
3-(5,6-Dichloro-pyridin-3-yl)-1S,5S-3,6-diazabicyclo[3.2.0]heptane and salts thereof are effective nicotinic receptor agonist compounds that demonstrated pharmacological effect for symptoms associated with attention-deficit/hyperactivity disorder.
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
17.07.2012
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!